Prudential Financial
TRML

Prudential Financial’s Tourmaline Bio TRML Stock Holding History

Prudential Financial’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,335
Closed -$1.47M – 2382
2024
Q4 		$1.47M Sell
72,335
-5,800
-7% -$146K ﹤0.01% 1434
2024
Q3 		$2.01M Buy
78,135
+5,800
+8% +$96.8K ﹤0.01% 1495
2024
Q2 		$930K Buy
72,335
+1,335
+2% +$21.5K ﹤0.01% 1869
2024
Q1 		$1.63M Buy
+71,000
New +$2.5M ﹤0.01% 1566

Other funds holding TRML

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Prudential Financial's TRML Position: Q1 2025 in Review

Prudential Financial sold out of Tourmaline Bio (TRML) in Q1 2025, closing a stake of 72,335 shares — an estimated $1.47M sold.

Prudential Financial first reported a position in TRML in Q1 2024 and held it in 4 quarters. The position peaked at $2.01M in Q3 2024. 107 funds tracked by Wall St. Rank hold TRML as of Q1 2025.

  • Prudential Financial reported no remaining Tourmaline Bio position as of Q1 2025 after selling out during the quarter.
  • Prudential Financial sold 72,335 Tourmaline Bio shares in Q1 2025, an estimated $1.47M.
  • Prudential Financial first reported a position in Tourmaline Bio in Q1 2024 and held it in 4 quarters.
  • Prudential Financial's Tourmaline Bio position peaked at $2.01M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Tourmaline Bio as of Q1 2025.

Based on Prudential Financial's 13F filing for Q1 2025, filed 13 May 2025.